Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIENCY

v2.4.0.8
STOCKHOLDERS' DEFICIENCY
6 Months Ended
Jun. 30, 2014
STOCKHOLDERS' DEFICIENCY  
STOCKHOLDERS' DEFICIENCY

NOTE 8 - STOCKHOLDERS’ DEFICIT

 

Board of Directors fees

 

As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to Philip M. Rice (CFO and a Director) in January, 2013, at an exercise price of $.12 per share.  The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter).  The warrants were valued at $10,381 using the Black Scholes pricing model relying on the following assumptions: volatility 131.97%; annual rate of dividends 0%; discount rate 0.27%.  In addition, Mr. Rice will receive $10,000 for each annual term served, paid quarterly.

 

As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to Thomas K. Cox in June, 2013, at an exercise price of $.40 per share.  The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter).  The warrants were valued at $15,873 using the Black Scholes pricing model relying on the following assumptions: volatility 145.67%; annual rate of dividends 0%; discount rate 0.25%.  In addition, Mr. Cox will receive $10,000 for each annual term served, paid quarterly.

 

As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to John B. Payne in July, 2013, at an exercise price of $.38 per share.  The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter).  The warrants were valued at $17,187 using the Black Scholes pricing model relying on the following assumptions: volatility 143.37%; annual rate of dividends 0%; discount rate 0.25%.  In addition, Mr. Payne will receive $10,000 for each annual term served, paid quarterly.

 

 

As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to John Gorman in November, 2013, at an exercise price of $.36 per share.  The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter).  The warrants were valued at $14,053 using the Black Scholes pricing model relying on the following assumptions: volatility 141.53%; annual rate of dividends 0%; discount rate 0.33%.  In addition, Mr. Gorman will receive $10,000 for each annual term served, paid quarterly.

 

As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to Philip M. Rice (CFO and a Director) in January, 2014, at an exercise price of $.38 per share.  The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter).  The warrants were valued at $13,460 using the Black Scholes pricing model relying on the following assumptions: volatility 121.33%; annual rate of dividends 0%; discount rate 0.44%.  In addition, Mr. Rice will receive $10,000 for each annual term served, paid quarterly.

 

As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to Thomas K. Cox in June, 2014, at an exercise price of $.19 per share.  The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter).  The warrants were valued at $7,311 using the Black Scholes pricing model relying on the following assumptions: volatility 138.05%; annual rate of dividends 0%; discount rate 0.41%.  In addition, Mr. Cox will receive $10,000 for each annual term served, paid quarterly.

 

The company recorded Directors Fees of $29,683 during the six months ended June 30, 2014, representing the fees expensed and the value of the vested warrants described above.

 

Stock Issuances

 

During the six months ended June 30, 2014, the Company received proceeds of $502,500 from the issuance of 3,433,334 shares of common stock and 1,308,333 common stock warrants and $233,000 from the exercise of 2,040,000 common stock warrants.  The Company also issued 4,955,000 shares of common stock upon conversion of $490,600 of 1% and 11% convertible debentures during the six months ended June 30, 2014.  The Company issued 416,667 shares of common stock to a non-related party shareholder relating to a stock purchase in December 2013.

 

Executive Compensation

 

As compensation for serving as Chief Financial Officer, the Company, quarterly, will issue warrants to purchase 50,000 shares of common stock to Philip M. Rice at the prevailing market price with a term of 5 years, provided that the preceding quarterly and annual filings were submitted in a timely and complaint manner, at which time such warrants would vest.  On March 31, 2014 the Company issued warrants to purchase 50,000 shares of common stock at $.17.  The warrants were valued at $13,460 using the Black Scholes pricing model relying on the following assumptions: volatility 128.35%; annual rate of dividends 0%; discount rate 0.44%.  On May 14, 2014, the Company issued warrants to purchase 50,000 shares of common stock at $.19.  The warrants were valued at $6,756 using the Black Scholes pricing model relying on the following assumptions: volatility 121.96%; annual rate of dividends 0%; discount rate 0.47%.

 

A summary of the status of the Company’s warrants is presented below.

 

 

June 30, 2014

December 31, 2013

 

Number of

Weighted Average

Number of

Weighted Average

 

Warrants

Exercise Price

Warrants

Exercise Price

 

 

 

 

 

Outstanding, beginning of year

16,900,539

                $       0.17

16,365,209

$         0.17

Issued

1,508,333

                     0.17

4,820,330

0.18

Exercised

(1,940,000)

                     0.13

(2,785,000)

0.16

Cancelled

(100,000)

                     0.30

-

-

Expired

(4,251,000)

                     0.22

(1,500,000)

0.32

 

 

 

 

Outstanding, end of period

12,117,873

               $       0.15

16,900,539

                $      0.17

 

Warrants outstanding and exercisable by price range as of June 30, 2014 were as follows:

 

Outstanding Warrants

Exercisable Warrants

 

Average

Weighted

Remaining

Weighted

Contractual

Exercise

Average

Range of

Number

Life in Years

Price

Number

Exercise Price

 

 

 

 

 

 

$  0.12

3,439,439

1.32

$  0.12

3,439,439

$  0.12

   0.125

4,036,097

0.88

0.125

4,036,097

      0.125

   0.15

2,358,333

1.69

0.15

2,358,333

    0.15

   0.17

50,000

4.75

0.17

50,000

   0.17

   0.19

100,000

3.91

0.19

72,500

   0.19

   0.20

250,000

2.84

0.20

250,000

   0.20

 0.22

477,004

2.12

0.22

477,004

   0.22

 0.25

707,000

4.02

0.25

707,000

0.25

  0.30

250,000

4.02

0.30

250,000

0.30

  0.33

250,000

4.01

0.33

250,000

0.33

  0.36

50,000

1.34

0.36

37,500

0.36

  0.38

100,000

2.29

0.38

75,000

0.38

  0.40

50,000

2.44

0.40

50,000

0.40

 

 

 

 

 

12,117,873

1.99

 

12,045,373

$ 0.15